| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/WNAN.1448 |
| P698 | PubMed publication ID | 28078811 |
| P2093 | author name string | Silvia De Paoli | |
| Jan Simak | |||
| P2860 | cites work | Platelet genomics and proteomics in human health and disease | Q24536151 |
| Nanoparticle-induced platelet aggregation and vascular thrombosis | Q28191813 | ||
| Application of ex vivo flow chamber system for assessment of stent thrombosis | Q28193586 | ||
| Characterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronics | Q30319016 | ||
| Interaction of gold nanoparticles with common human blood proteins. | Q30383615 | ||
| Influence of nanoporesize on platelet adhesion and activation | Q30842800 | ||
| Biocompatibility of poly(ether)urethane-gold nanocomposites | Q33251928 | ||
| Surface morphology and adsorbed proteins affect phagocyte responses to nano-porous alumina | Q33264456 | ||
| Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate | Q33314463 | ||
| Optimizing platelet transfusion therapy | Q33361167 | ||
| Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute | Q33382776 | ||
| Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation | Q33386421 | ||
| Procoagulant behavior and platelet microparticle generation on nanoporous alumina | Q33478827 | ||
| The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes | Q33499204 | ||
| Identification of serum proteins bound to industrial nanomaterials | Q34048665 | ||
| Experimental models of gram-negative sepsis | Q34117180 | ||
| What really is blood compatibility? | Q34192463 | ||
| Effects of long and short carboxylated or aminated multiwalled carbon nanotubes on blood coagulation | Q34341520 | ||
| Animal models of acute lung injury | Q34795312 | ||
| Mechanisms of thrombus formation | Q34815800 | ||
| Determinants of the thrombogenic potential of multiwalled carbon nanotubes | Q35087569 | ||
| The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation | Q35686931 | ||
| The influence of biomaterials on endothelial cell thrombogenicity | Q35792945 | ||
| Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine) dendrimers | Q46821943 | ||
| The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets | Q46893970 | ||
| Size-dependent effects of nanoparticles on enzymes in the blood coagulation cascade | Q47449131 | ||
| Adsorption and adhesion of blood proteins and fibroblasts on multi-wall carbon nanotubes | Q47720208 | ||
| The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood | Q47940680 | ||
| Disruption and activation of blood platelets in contact with an antimicrobial composite coating consisting of a pyridinium polymer and AgBr nanoparticles. | Q50581653 | ||
| Development of a method for magnetic labeling of platelets. | Q50670822 | ||
| Surface modification of silica core-shell nanocapsules: biomedical implications. | Q50740307 | ||
| Mechanical, tribological, and biocompatibility properties of ZrN-Ag nanocomposite films. | Q53025830 | ||
| Fibrinogen and albumin adsorption on titanium nanoroughness gradients. | Q53715427 | ||
| Thrombus inducing property of atomically thin graphene oxide sheets. | Q54589819 | ||
| Polystyrene nanoparticles affecting blood coagulation | Q57904138 | ||
| Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity | Q58390475 | ||
| Current methods of assessing platelet function: relevance to transfusion medicine | Q36078677 | ||
| Microvascular thrombosis models in venules and arterioles in vivo. | Q36090998 | ||
| Shock and hemorrhage: an overview of animal models | Q36351630 | ||
| Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system | Q36492944 | ||
| Current options in platelet function testing | Q36650059 | ||
| Experimental models of thrombosis and atherosclerosis | Q36715505 | ||
| Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro | Q36760929 | ||
| Fibrinolysis, inflammation, and regulation of the plasminogen activating system | Q36884356 | ||
| Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles | Q36933014 | ||
| Preclinical models of intracerebral hemorrhage: a translational perspective | Q37023923 | ||
| Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution | Q37036373 | ||
| Nanotoxicity: the growing need for in vivo study | Q37045340 | ||
| Cell adhesion mechanisms in platelets | Q37049884 | ||
| Endothelium-platelet interactions in inflammatory lung disease | Q37215693 | ||
| Phagocytosis of liposomes by human platelets | Q37227307 | ||
| Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo | Q37456312 | ||
| Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance | Q37471523 | ||
| Protein-phospholipid interactions in blood clotting | Q37686828 | ||
| Thromboelastographic study of biomaterials. | Q37768388 | ||
| Multistability in platelets and their response to gold nanoparticles. | Q37839331 | ||
| Thrombin activatable fibrinolysis inhibitor. | Q37883138 | ||
| Thrombin generation in hemorrhage control and vascular occlusion | Q37900072 | ||
| Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. | Q38299285 | ||
| Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles. | Q39515269 | ||
| Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis | Q39714417 | ||
| The influence of glancing angle deposited nano-rough platinum surfaces on the adsorption of fibrinogen and the proliferation of primary human fibroblasts. | Q39856286 | ||
| Blood clot initiation by mesocellular foams: dependence on nanopore size and enzyme immobilization. | Q39909283 | ||
| Colloidal Confinement of Polyphosphate on Gold Nanoparticles Robustly Activates the Contact Pathway of Blood Coagulation. | Q40255085 | ||
| Blood compatible carbon nanotubes--nano-based neoproteoglycans | Q42754172 | ||
| Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro | Q42788361 | ||
| Synthesis, nanofeatures, in vitro thrombus lysis activity and in vivo thrombolytic activity of poly-alpha,beta-aspartyl-L-alanine | Q42956431 | ||
| Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors | Q43279703 | ||
| Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation | Q43288028 | ||
| Liposomes and blood cells: a flow cytometric study | Q44691087 | ||
| Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles | Q44765785 | ||
| A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions | Q45880969 | ||
| The role of nanoparticle size in hemocompatibility. | Q46018270 | ||
| On the interaction of fluorophore-encapsulating PEGylated lecithin liposomes with hamster and human platelets | Q46090716 | ||
| Investigation of the interaction of biodegradable micro- and nanoparticulate drug delivery systems with platelets | Q46562013 | ||
| Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles | Q46678341 | ||
| P433 | issue | 5 | |
| P921 | main subject | thrombosis | Q261327 |
| nanomaterial | Q967847 | ||
| P577 | publication date | 2017-01-11 | |
| P1433 | published in | Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology | Q24056192 |
| P1476 | title | The effects of nanomaterials on blood coagulation in hemostasis and thrombosis | |
| P478 | volume | 9 |
| Q60306460 | Nanotechnology-enabled materials for hemostatic and anti-infection treatments in orthopedic surgery |
| Q91717369 | Superhydrophobic hemostatic nanofiber composites for fast clotting and minimal adhesion |
| Q57181647 | T-T molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents |
| Q90574278 | The Hemocompatibility of Nanoparticles: A Review of Cell-Nanoparticle Interactions and Hemostasis |
Search more.